Century Therapeutics, Inc. (IPSC)
NASDAQ: IPSC · Real-Time Price · USD
0.897
-0.012 (-1.33%)
At close: Jan 21, 2025, 4:00 PM
0.900
+0.003 (0.32%)
After-hours: Jan 21, 2025, 7:23 PM EST
Century Therapeutics Stock Forecast
IPSC's stock price has decreased by -76.57% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 4 analysts with 12-month price forecasts for IPSC stock have an average target of 11, with a low estimate of 4.00 and a high estimate of 24. The average target predicts an increase of 1,126.04% from the current stock price of 0.90.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for IPSC stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 3 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $12 → $4 | Buy | Maintains | $12 → $4 | +345.83% | Dec 30, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $17 → $11 | Strong Buy | Maintains | $17 → $11 | +1,126.04% | Nov 7, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $9 → $5 | Strong Buy | Maintains | $9 → $5 | +457.29% | Nov 6, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $11 → $9 | Strong Buy | Maintains | $11 → $9 | +903.12% | Aug 15, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $9 → $12 | Buy | Maintains | $9 → $12 | +1,237.49% | Jun 17, 2024 |
Financial Forecast
Revenue This Year
7.39M
from 2.24M
Increased by 230.51%
Revenue Next Year
9.74M
from 7.39M
Increased by 31.87%
EPS This Year
-1.66
from -2.30
EPS Next Year
-1.35
from -1.66
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 32.5M | 46.5M | 4.2M |
| Avg | 7.4M | 9.7M | 4.1M |
| Low | 2.5M | 392,000 | 3.9M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 1,355.2% | 529.0% | -56.9% |
| Avg | 230.5% | 31.9% | -58.1% |
| Low | 10.4% | -94.7% | -59.8% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -1.52 | 1.37 | -2.01 |
| Avg | -1.66 | -1.35 | -1.95 |
| Low | -1.72 | -1.94 | -1.87 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.